Results 61 to 70 of about 4,155 (158)

Spondyloarthritis Research and Treatment Network Recommendations for the Referral of Adults With Chronic Back Pain and Suspected Axial Spondyloarthritis to a Rheumatologist

open access: yesACR Open Rheumatology, Volume 8, Issue 9, September 2026.
Objective In the United States, axial spondyloarthritis (axSpA) diagnosis is delayed up to 14 years preventing effective management. We convened a multidisciplinary clinician and patient group to develop recommendations for rheumatology referral of adults with chronic back pain.
Maureen Dubreuil   +15 more
wiley   +1 more source

Hematological Inflammation Indices Are Associated With Active Uveitis in Ankylosing Spondylitis

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 17, September 2026.
Hematological inflammation indices reflect the systemic inflammatory burden in ankylosing spondylitis. Patients with active uveitis exhibit a distinct pro‐inflammatory profile characterised by increased NLR, PLR, SII, SIRI, and AISI, along with decreased HALP and CALLY scores.
Mesude Seda Aydoğdu, Zarife Ekici Gök
wiley   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

open access: yesArthritis &Rheumatology, Volume 78, Issue 8, Page 1674-1686, August 2026.
Objective To evaluate the efficacy and safety of guselkumab, an interleukin‐23p19 subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor (TNF) inhibitor.
Alexis Ogdie   +12 more
wiley   +1 more source

Sex Differences in Medication Discontinuation in Axial Spondyloarthritis

open access: yesArthritis Care &Research, Volume 78, Issue 7, Page 914-924, July 2026.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or JAK inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we assessed ...
Rachael Stovall   +9 more
wiley   +1 more source

A Rare Association of Interstitial Lung Disease in Ankylosing Spondylitis: A Case Report and Review of Early Detection and Multidisciplinary Management

open access: yesRespirology Case Reports, Volume 14, Issue 7, July 2026.
Ankylosing spondylitis may rarely present with extra‐articular pulmonary involvement, including early interstitial lung disease that can be missed on routine chest radiography. This case highlights the value of high‐resolution CT and pulmonary function testing for early detection, as well as the importance of multidisciplinary management. Escalation to
Stefani Larasati, Awalia
wiley   +1 more source

A single determination of C-reactive protein does not suffice to declare a patient with a diagnosis of axial spondyloarthritis ‘CRP-negative’

open access: yesArthritis Research & Therapy, 2018
Background To be eligible to receive treatment with an anti-tumour necrosis factor (TNF), non-radiographic axial spondyloarthritis (nr-axSpA) patients require either elevated levels of C-reactive protein (CRP) (CRP > upper limit of normal (ULN)) or ...
Robert Landewé   +3 more
doaj   +1 more source

Zone specific analysis of radiographic pelvic enthesitis in axial spondyloarthritis: identification and associations with mobility, function, and disease activity [PDF]

open access: yesARP Rheumatology
Objectives: To evaluate the frequency of radiographic pelvic enthesitis in patients with axial spondyloarthritis (axSpA), focusing on zone-specific entheseal sites and their associations with disease activity, mobility, and functional outcomes. Methods:
Kemal Erol   +2 more
doaj  

Sacroiliac and spine imaging in spondyloarthritis: Does phenotype or sex matter?

open access: yesAdvances in Rheumatology
Background Spondyloarthritis (SpA) encompasses a spectrum of immune-mediated inflammatory conditions primarily affecting the axial skeleton, including sacroiliitis and spondylitis, each with distinct features.
Gabriel Caetano Pereira   +5 more
doaj   +1 more source

Coexistence of spondyloarthritis and joint hypermobility syndrome: rare or unknown association?

open access: yesReumatismo, 2017
We report two cases of siblings presenting coexisting non-radiographic axial spondyloartrhritis and joint hypermobility syndrome, complaining of back pain with morning stiffness, enthesitis, peripheral arthralgia, high erythrocyte sedimentation rate and ...
J.B. Pinto Carneiro   +3 more
doaj   +1 more source

TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS

open access: yesНаучно-практическая ревматология, 2016
The paper provides guidelines for the use of tumor necrosis factor-α  (TNF-α) inhibitors in the treatment of patients with axial spondyloarthritis  (axSpA), including ankylosing spondylitis.
S. A. Lapshina   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy